SCHEMBL132899

SCHEMBL132899

SC1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4354716 1.00
SCHEMBL6624662 1.00
Hydrochloric Acid SCHEMBL9855170 0.97
Hydrochloric Acid SCHEMBL9855179 0.97
Hydrochloric Acid SCHEMBL27472439 0.97
Methane SCHEMBL27305703 0.97
Hydrochloric Acid SCHEMBL6168410 0.97
Formamide SCHEMBL27280835 0.84
SCHEMBL3064287 0.81
SCHEMBL1068577 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115093418-A [1,2,3] triazolo [4,5-d ] pyrimidine derivatives having affinity for cannabinoid type 2 receptors 豪夫迈·罗氏有限公司 2022-09-23 CN claimed
CN-102264744-A Improved process for producing carbapenem side chain intermediate 2011-11-30 CN claimed
US-20090324580-A1 Use of Inhibitors of Scavenger Receptor Class Proteins for the Treatment of Infectious Diseases CENIX BIOSCIENCE GMBH (DE) 2009-12-31 US claimed
CN-101592615-A The content assaying method of side chains of carbapenem compound TIANJIN TASLY GROUP CO LTD (CN) 2009-12-02 CN claimed
EP-1991215-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES Cenix Bioscience GmbH (DE) 2008-11-19 EP claimed
WO-2007101710-A1 USE OF INHIBITORS OF SCAVENGER RECEPTOR CLASS PROTEINS FOR THE TREATMENT OF INFECTIOUS DISEASES CENIX BIOSCIENCE GMBH (DE) 2007-09-13 WO claimed
US-7166594-B2 Antibacterial activity AVENTIS PHARMA S.A. (FR) 2007-01-23 US claimed
EP-0989994-B1 STREPTOGRAMINES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM AVENTIS PHARMA SA (FR) 2005-04-20 EP claimed
EP-1353929-B1 STREPTOGRAMIN DERIVATIVES PREPARATION THEREOF AND COMPOSITIONS CONTAINING SAME AVENTIS PHARMA SA (FR) 2005-03-16 EP claimed
US-20040236118-A1 Pyrrolidine derivatives and method of synthesizing these EIZAI CO., LTD (JP) 2004-11-25 US claimed
WO-1998007692-A1 3-MERCAPTOPYRROLIDINES AS FARNESYL PROTEIN TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1998-02-26 WO claimed
US-5629419-A Process for preparing 4-mercaptopyrrolidine intermediate compounds and a process for their use in preparing carbapenem -2-em-3 carboxylic acids TANABE SEIYAKU CO., LTD. (JP) 1997-05-13 US claimed
WO-1997006138-A1 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS ZENECA LIMITED (GB) 1997-02-20 WO claimed
EP-0551993-B1 Pyrrolidine derivatives and process for preparing the same SUMITOMO PHARMA (JP) 1996-07-10 EP claimed
EP-0713866-A1 Process for preparing 4-mercaptopyrrolidine compound TANABE SEIYAKU CO., LTD. (JP) 1996-05-29 EP claimed
EP-0551993-A1 Pyrrolidine derivatives and process for preparing the same SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1993-07-21 EP claimed
EP-0135410-B1 SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC SANTE (FR) 1988-09-21 EP claimed
EP-0191662-B1 PRISTINAMYCINE IIB DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC SANTE (FR) 1988-06-01 EP claimed
EP-0133097-B1 SYNERGISTIN DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF RHONE-POULENC SANTE (FR) 1987-03-04 EP claimed
US-4618599-A WATER SOLUBILITY RHONE-POULENC SANTE (FR) 1986-10-21 US claimed